Do probiotics help or hurt in bacterial overgrowth?

Clinicians disagree, and the disagreement is genuine rather than a gap somebody could close by reading more. The argument is whether adding organisms helps a disordered small intestine or adds to a population problem, and it has not been settled by trials of the size needed to settle it.

Are some types safer than others in this situation?

Spore-forming and soil-based products are often argued to behave differently from lactic acid strains here, because they are proposed to transit rather than colonise. That is a mechanistic argument, not a demonstrated outcome difference, and we would not present it as one.

Why do reports vary so much?

Because probiotic is a category, not a product. Different species, strains, doses and formulations behave differently, so two people reporting opposite results may not have taken comparable things at all.

Does the strain number on the label matter?

The strain designation matters more than the count. Evidence attaches to specific strains, not to species, so a product naming only a species and a colony count is not telling you what was studied.

What should I do with this?

Treat it as an open question and take it to a clinician who knows your history rather than to a comparison table. This is one of the few topics here where we think a confident answer would be a worse product than an honest shrug.

Probiotics

By B. Gray Randolph · Updated August 5, 2026

Most pages on this either recommend a product or warn you off the category. We are not going to do either, because the disagreement is real and pretending it is settled would be the dishonest part.

What is actually contested

Whether adding organisms helps a disordered small intestine or adds to a population problem. Some clinicians use probiotics routinely in this setting; others argue they worsen it specifically because the issue is bacteria in the wrong place. Both positions are held by serious people and neither has been settled by trials of the size that would settle it.

That is the whole disagreement, and it is worth understanding rather than outsourcing, because it determines whether any given recommendation you read makes sense on its own terms. Patients are about as split on it as the clinicians, and they tend to argue about named products rather than about the category, which is the right instinct even where the evidence is thin.

Why "probiotics" is not one thing

Probiotic is a category, not a product. Different species, strains, doses and formulations behave differently, and evidence attaches to specific STRAINS rather than to species. So a product naming only a species and a colony count is not telling you what was studied, and two people reporting opposite outcomes may not have taken comparable things.

This is the single most useful thing to carry away, because it explains why the anecdotes conflict so violently and why a category-level recommendation is close to meaningless.

What is not settled here

The spore-forming and soil-based argument deserves naming precisely. The proposal is that these transit rather than colonise, and therefore behave differently in a small intestine that already has too many organisms. That is a mechanistic argument. It is not a demonstrated outcome difference, and we are not going to render it as one just because it is the more interesting story.

What the surrounding evidence looks like

Pimentel M et al., American Journal of Gastroenterology 2020 Clinical guideline

The guideline for the condition most of this discussion orbits rates five of six recommendations as resting on very low quality evidence. Probiotics are not the weak spot in an otherwise firm field; the field is like this.

What this page will not do

No ranking, no dosing, no protocol, no product recommendation. Ranking products in a category where the evidence attaches to individual strains, and where clinicians disagree about the direction of effect, would imply a basis for comparison that does not exist.

If you want a specific answer, the person to ask is a clinician who knows your history. We think that is a better outcome for you than a confident table, even though a confident table would perform better.

Common questions

Do probiotics help or hurt in bacterial overgrowth?: Clinicians disagree, and the disagreement is genuine rather than a gap somebody could close by reading more. The argument is whether adding organisms helps a disordered small intestine or adds to a population problem, and it has not been settled by trials of the size needed to settle it.
Are some types safer than others in this situation?: Spore-forming and soil-based products are often argued to behave differently from lactic acid strains here, because they are proposed to transit rather than colonise. That is a mechanistic argument, not a demonstrated outcome difference, and we would not present it as one.
Why do reports vary so much?: Because probiotic is a category, not a product. Different species, strains, doses and formulations behave differently, so two people reporting opposite results may not have taken comparable things at all.
Does the strain number on the label matter?: The strain designation matters more than the count. Evidence attaches to specific strains, not to species, so a product naming only a species and a colony count is not telling you what was studied.
What should I do with this?: Treat it as an open question and take it to a clinician who knows your history rather than to a comparison table. This is one of the few topics here where we think a confident answer would be a worse product than an honest shrug.